Literature DB >> 9115522

Managing recurrent nonischemic chest pain in the emergency department.

M J Tueth1.   

Abstract

Many patients who seek emergency evaluation for recurrent chest pain have had negative cardiac evaluations, sometimes including normal coronary angiograms. Despite reassurance, many of these patients return to emergency departments with complaints of chest pain. Studies have shown that one third to one half of these patients suffer from panic disorder characterized by attacks of intense fear accompanied by chest pain or discomfort, nausea, and shortness of breath. If panic disorder is identified, it can be successfully treated. This article explores the causes of recurrent nonischemic chest pain and offers treatment recommendations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9115522     DOI: 10.1016/s0735-6757(97)90094-2

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  4 in total

1.  Anxiety disorder in patients with non-specific chest pain in the emergency setting.

Authors:  N S Demiryoguran; O Karcioglu; H Topacoglu; S Kiyan; D Ozbay; E Onur; T Korkmaz; O F Demir
Journal:  Emerg Med J       Date:  2006-02       Impact factor: 2.740

Review 2.  The Interdisciplinary Management of Acute Chest Pain.

Authors:  Raphael R Bruno; Norbert Donner-Banzhoff; Wolfgang Söllner; Thomas Frieling; Christian Müller; Michael Christ
Journal:  Dtsch Arztebl Int       Date:  2015-11-06       Impact factor: 5.594

3.  Anxiety and depressive disorders in an emergency department ward of a general hospital: a control study.

Authors:  C Marchesi; E Brusamonti; C Borghi; A Giannini; R Di Ruvo; F Minneo; C Quarantelli; C Maggini
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

4.  The Value of Chinese Version GAD-7 and PHQ-9 to Screen Anxiety and Depression in Chinese Outpatients with Atypical Chest Pain.

Authors:  Qiuzhen Lin; Ousseina Bonkano; Keke Wu; Qiming Liu; Toure Ali Ibrahim; Ling Liu
Journal:  Ther Clin Risk Manag       Date:  2021-05-18       Impact factor: 2.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.